
Servier to bag Shire's cancer business
The deal includes the acute lymphoblastic leukemia (ALL) drug pegaspargase (Oncaspar) and late stage ALL candidate drug calaspargase...

Protein keeps breast cancer metastases at bay
Three years ago, the team of Roger Gomez at IRB Barcelona discovered that certain mutations in the MAF gene of breast cancer patients correlated with...

Motif Bio to submit NDA for iclaprim
In the US, 3.6 million patients of this population are hospitalised annually. Motif Bio said the antibiotic may be suitable for first-line...

Locking malaria parasites into red blood cells
The findings reported in Nature could help prevent over 400,000 deaths per annum that are caused to widespread drug resistance of the parasite, whose...

EMA recommends seven new drugs for market
About 5% to 7% of patients with hemophilia A develop a resistance to treatment with recombinant factor VIII products because they carry so-called...

PharmaMar in licence deal with Seattle Genetics
Under the deal, Seattle Genetics will get the exclusive worldwide rights to some proprietary sea-derived toxic payloads of PharmaMar for the...

Algorithm tracks cancer type down to methylation pattern
The group headed by Stefan Pfister at German Cancer Research Center (Heidelberg) reported in Nature that the availability of their method...